Member Spotlight: "CTI Molecular Imaging"
Speaker(s): Walter Cromer, CTI

CTI Molecular Imaging Inc. is a 20 year old Knoxville, Tennessee-based company. CTI is the leading provider of positron emission tomography (PET) imaging equipment and services. We enable healthcare providers, physicians, and their patients to improve the diagnosis and treatment of cancer, cardiac disease, and neurological disorders. We provide the most complete and integrated product line, including PET scanners, cyclotrons, molecular probes, detector materials, and support services. Our strategy is to captialize on our breadth in PET and provide the only "total solution" for healthcare providers.

CTI is a public company with a rapid growth rate. In 2001, CTI implemented Oracle 11i Financials including Order Management, Advanced PRicing, Procurement, A/R, A/P, iProcurement, Receiving, Project Accounting, General Ledger and Cash Management in a multi-org structure supporting USD and GMB currencies. This rollout was for one operating unit, PETNet Pharmaceuticals. In February 2004, CTI extended the deployment of Oracle 11i to include all operating units and added Discret Manufacturing, Oracle Time and Labor, iExpense and Shipping.